| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.SEMCDB.2015.08.005 |
| P8608 | Fatcat ID | release_4nnrj274cbh6zdb63unsi7zxyy |
| P3181 | OpenCitations bibliographic resource ID | 1358247 |
| P932 | PMC publication ID | 4662909 |
| P698 | PubMed publication ID | 26277544 |
| P2093 | author name string | M Celeste Simon | |
| Bo Qiu | |||
| P2860 | cites work | SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth | Q24309283 |
| Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence | Q24310386 | ||
| Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling | Q24536092 | ||
| Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia | Q40835443 | ||
| Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency | Q40890351 | ||
| Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1. | Q41983843 | ||
| Sterol regulatory element binding protein-dependent regulation of lipid synthesis supports cell survival and tumor growth. | Q42874599 | ||
| The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma | Q44043146 | ||
| Characterization of a novel PERK kinase inhibitor with antitumor and antiangiogenic activity | Q46379013 | ||
| Validation of mammalian target of rapamycin biomarker panel in patients with clear cell renal cell carcinoma. | Q54325230 | ||
| Hypoxia-Inducible Factors and the Response to Hypoxic Stress | Q24629323 | ||
| mTOR signaling in growth control and disease | Q24634174 | ||
| Brick by brick: metabolism and tumor cell growth | Q24656187 | ||
| Inhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growth | Q24800550 | ||
| Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel? | Q26852282 | ||
| Therapeutic targeting of cellular metabolism in cells with hyperactive mTORC1: a paradigm shift | Q26999365 | ||
| Endoplasmic reticulum stress in malignancy | Q27006434 | ||
| Hypoxia-inducible factors in physiology and medicine | Q27013770 | ||
| Nutrient-sensing mechanisms across evolution | Q27015819 | ||
| HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression | Q27025886 | ||
| Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis | Q28218978 | ||
| Stimulation of the AMP-activated protein kinase leads to activation of eukaryotic elongation factor 2 kinase and to its phosphorylation at a novel site, serine 398 | Q28237559 | ||
| Coordinated regulation of protein synthesis and degradation by mTORC1 | Q28244300 | ||
| RAS oncogenes: weaving a tumorigenic web | Q28250360 | ||
| The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation | Q28291406 | ||
| Regulation of hepatic lipogenesis by the transcription factor XBP1 | Q28507784 | ||
| Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis | Q28595034 | ||
| The unfolded protein response: from stress pathway to homeostatic regulation | Q29547396 | ||
| Activation of a metabolic gene regulatory network downstream of mTOR complex 1 | Q29615179 | ||
| Signal transduction by reactive oxygen species | Q29615230 | ||
| AMPK: a nutrient and energy sensor that maintains energy homeostasis | Q29615410 | ||
| Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia | Q29616650 | ||
| Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity | Q29616651 | ||
| c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism | Q29617213 | ||
| Metabolic reprogramming: a cancer hallmark even warburg did not anticipate | Q29617612 | ||
| Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway | Q29617805 | ||
| MYC on the path to cancer | Q29619979 | ||
| Pancreatic cancers require autophagy for tumor growth | Q29620331 | ||
| mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway | Q30425628 | ||
| Triacylglycerol synthesis enzymes mediate lipid droplet growth by relocalizing from the ER to lipid droplets. | Q30541918 | ||
| The tumor suppressor folliculin regulates AMPK-dependent metabolic transformation | Q33685916 | ||
| Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. | Q33863055 | ||
| Quantitative flux analysis reveals folate-dependent NADPH production. | Q33924205 | ||
| Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity | Q34181503 | ||
| Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell death | Q34393322 | ||
| Hypoxia inducible factor activates the transforming growth factor-alpha/epidermal growth factor receptor growth stimulatory pathway in VHL(-/-) renal cell carcinoma cells | Q34536583 | ||
| Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. | Q34626763 | ||
| mTORC1-mediated translational elongation limits intestinal tumour initiation and growth | Q35007110 | ||
| Deregulated Myc requires MondoA/Mlx for metabolic reprogramming and tumorigenesis | Q35079601 | ||
| The role for autophagy in cancer | Q35242506 | ||
| Genetic and functional studies implicate HIF1α as a 14q kidney cancer suppressor gene | Q35452783 | ||
| Transcriptional regulatory circuits controlling mitochondrial biogenesis and function | Q35683727 | ||
| The FIH hydroxylase is a cellular peroxide sensor that modulates HIF transcriptional activity | Q35880387 | ||
| Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism | Q36319414 | ||
| PERK is required in the adult pancreas and is essential for maintenance of glucose homeostasis | Q36435206 | ||
| ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth | Q36497999 | ||
| AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo | Q36532941 | ||
| Translational control in cancer etiology | Q36555212 | ||
| Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids | Q36895786 | ||
| Dysregulated mTORC1 renders cells critically dependent on desaturated lipids for survival under tumor-like stress | Q36902914 | ||
| Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis | Q37019194 | ||
| Lipid droplets and cellular lipid metabolism | Q37157015 | ||
| Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells | Q37261134 | ||
| Hypoxia-inducible factor 2 regulates hepatic lipid metabolism | Q37302297 | ||
| MYC-induced cancer cell energy metabolism and therapeutic opportunities | Q37438881 | ||
| SIRT7 represses Myc activity to suppress ER stress and prevent fatty liver disease | Q37463911 | ||
| Hypoxic regulation of glutamine metabolism through HIF1 and SIAH2 supports lipid synthesis that is necessary for tumor growth | Q37576769 | ||
| Loss of the tumor suppressor LKB1 promotes metabolic reprogramming of cancer cells via HIF-1α. | Q37599925 | ||
| The AMP-activated protein kinase (AMPK) and cancer: many faces of a metabolic regulator | Q38184207 | ||
| Cellular and metabolic functions for autophagy in cancer cells | Q38256306 | ||
| Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis | Q38324237 | ||
| HIF2α-Dependent Lipid Storage Promotes Endoplasmic Reticulum Homeostasis in Clear-Cell Renal Cell Carcinoma. | Q38892263 | ||
| Hif-2α promotes degradation of mammalian peroxisomes by selective autophagy | Q38936369 | ||
| In vivo HIF-mediated reductive carboxylation is regulated by citrate levels and sensitizes VHL-deficient cells to glutamine deprivation | Q39030433 | ||
| Androgens regulate prostate cancer cell growth via an AMPK-PGC-1α-mediated metabolic switch. | Q39067480 | ||
| HIF2α acts as an mTORC1 activator through the amino acid carrier SLC7A5. | Q39252741 | ||
| Deregulated MYC expression induces dependence upon AMPK-related kinase 5. | Q39372073 | ||
| Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression. | Q39382008 | ||
| Differential dependence of hypoxia-inducible factors 1 alpha and 2 alpha on mTORC1 and mTORC2. | Q39926383 | ||
| Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis | Q40002274 | ||
| HIF-dependent antitumorigenic effect of antioxidants in vivo | Q40085629 | ||
| Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells | Q40310345 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell biology | Q7141 |
| cell growth | Q189159 | ||
| P304 | page(s) | 3-10 | |
| P577 | publication date | 2015-07-01 | |
| P1433 | published in | Seminars in Cell & Developmental Biology | Q14330411 |
| P1476 | title | Oncogenes strike a balance between cellular growth and homeostasis | |
| P478 | volume | 43 |
| Q100762137 | 2-Oxoglutarate-dependent dioxygenases in cancer |
| Q91844850 | 4-O-Methylascochlorin inhibits the prolyl hydroxylation of hypoxia-inducible factor-1α, which is attenuated by ascorbate |
| Q45835023 | Cancer cell dormancy: mechanisms and implications of cancer recurrence and metastasis |
| Q37705955 | Co-targeting translation and proteasome rapidly kills colon cancer cells with mutant RAS/RAF via ER stress |
| Q58772577 | Effect of mechanistic target of rapamycin inhibitors on postrenal transplantation malignancy: A nationwide cohort study |
| Q38954615 | Emerging tale of UPR and cancer: an essentiality for malignancy. |
| Q92700885 | Hexokinase 2 dimerization and interaction with voltage-dependent anion channel promoted resistance to cell apoptosis induced by gemcitabine in pancreatic cancer |
| Q37097416 | Identification of lineariifolianoid A as a novel dual NFAT1 and MDM2 inhibitor for human cancer therapy |
| Q26774859 | Lipid metabolic reprogramming in cancer cells |
| Q38695079 | MiR-204 Regulates Cell Proliferation and Invasion by Targeting EphB2 in Human Cervical Cancer |
| Q64089543 | MicroRNA-451 Inhibits Migration of Glioblastoma while Making It More Susceptible to Conventional Therapy |
| Q50457874 | Myc inhibits JNK-mediated cell death in vivo. |
| Q42321596 | Oncogenic regulation of tumor metabolic reprogramming |
| Q38961810 | Oxygen availability and metabolic adaptations |
| Q90044947 | Patched1 haploinsufficiency severely impacts intermediary metabolism in the skin of Ptch1+/-/ODC transgenic mice |
| Q39986242 | Targeting ACLY sensitizes castration-resistant prostate cancer cells to AR antagonism by impinging on an ACLY-AMPK-AR feedback mechanism. |
| Q26775306 | The second European interdisciplinary Ewing sarcoma research summit--A joint effort to deconstructing the multiple layers of a complex disease |
Search more.